Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats
The synthetic cathinone α-pyrrolidinopentiophenone (α-PVP) has been associated with bizarre public behavior in users. Association of such behavior with extended binges of drug use motivates additional investigation, particularly since a prior study found that half of male rats experience a binge of exceptionally high intake, followed by sustained lower levels of self-administration during the acquisition of intravenous self-administration (IVSA) of a related drug, 3,4-methylenedioxypyrovalerone.
The binge-like acquisition pattern is novel for rat IVSA; thus, the present study sought to determine if this effect generalizes to IVSA of α-PVP in female rats.
Female Wistar rats were trained in IVSA of α-PVP (0.05 mg/kg/inf) in experimental chambers containing an activity wheel. Groups were trained with the wheels fixed (No-Wheel group), fixed for the initial 5 days of acquisition or free to move throughout acquisition (Wheel group). The groups were next subjected to a wheel access switch and then all animals to dose-substitution (0.0125–0.3 mg/kg/inf) with the wheels alternately fixed and free to move.
Approximately half of the rats initiated their IVSA pattern with a binge day of exceptionally high levels of drug intake, independent of wheel access condition. Wheel activity was much lower in the No-Wheel group in the wheel switch post-acquisition. Dose-effect curves were similar for wheel access training groups, for binge/no binge phenotypic subgroups and were not altered with wheel access during the dose-substitution.
This confirms the high reinforcer effectiveness of α-PVP in female rats and the accompanying devaluation of wheel activity as a naturalistic reward.
KeywordsReward “Bath salts” Psychostimulants Synthetic drugs Wheel running
This work was funded by support from the US Public Health Service National Institutes of Health (R01DA042211) which had no direct input on the design, conduct, analysis, or publication of the findings. Conception and securing funding for the project: MAT, TJD; study design: MAT, MJ-P, JDN; data collection and initial analysis: MJ-P, ELH, YG, SAV, KMC, JDN; statistical analysis and figure creation: MAT; manuscript drafting: MAT, MJ-P. All authors have read and approved the manuscript. The authors declare no competing financial interests. This is manuscript #29574 from The Scripps Research Institute.
Compliance with ethical standards
All experimental procedures were conducted under protocols approved by the Institutional Care and Use Committees of The Scripps Research Institute and in a manner consistent with the Guide for the Care and Use of Laboratory Animals (National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals. et al. 2011).
Conflict of interest
The authors declare that they have no conflict of interest.
- Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015a) In vivo potency and efficacy of the novel cathinone alpha-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232:3045–3055CrossRefPubMedPubMedCentralGoogle Scholar
- Alvarez SC, Benz GR, Elder R, Lew M, Sneider J (2012) Intervention season 12, episode 8: Skyler & Jessa. In: Mettler S (ed) intervention. A & E, aetv.com
- Anderson C (2015) Flakka, synthetic drug behind increasingly bizarre crimes. Associated Press, http://hosted.ap.org/dynamic/stories/U/US_FLAKKAS_EMERGENCE: http://hosted.ap.org/dynamic/stories/U/US_FLAKKAS_EMERGENCE
- Anneken JH, Angoa-Perez M, Kuhn DM (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: beta-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem 133:211–222CrossRefPubMedPubMedCentralGoogle Scholar
- Antonowicz JL, Metzger AK, Ramanujam SL (2011) Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 33(640):e5–e6Google Scholar
- Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38:552–562CrossRefPubMedGoogle Scholar
- Benzie F, Hekman K, Cameron L, Wade DR, Smolinske S (2011) Emergency department visits after use of a drug sold as "bath salts"—Michigan, November 13, 2010–March 31, 2011. MMWR Morb Mortal Wkly Rep 60:624–627Google Scholar
- D'Oench P (2015) Exclusive: surveillance tape shows mom accused of abandoning baby after taking Flakka. CBSMiami, http://miami.cbslocal.com/2015/05/04/exclusive-surveillance-tape-shows-mom-accused-of-abandoning-baby-after-taking-flakka/: http://miami.cbslocal.com/2015/05/04/exclusive-surveillance-tape-shows-mom-accused-of-abandoning-baby-after-taking-flakka/
- Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530–536CrossRefPubMedPubMedCentralGoogle Scholar
- Marcondes FK, Bianchi FJ, Tanno AP (2002) Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol = Rev Bras Biol 62:609–614Google Scholar
- McFadden LM, Hoonakker AJ, Vieira-Brock PL, Stout KA, Sawada NM, Ellis JD, Allen SC, Walters ET, Nielsen SM, Gibb JW, Alburges ME, Wilkins DG, Hanson GR, Fleckenstein AE (2011) Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration. Synapse 65:771–777CrossRefPubMedPubMedCentralGoogle Scholar
- Milian J (2015) Riviera Beach Police: man smoking flakka wielded machete at stepdad. PalmBeachPostcom, http://www.palmbeachpost.com/news/news/crime-law/riviera-beach-police-man-smoking-flakka-wielded-ma/nmW5k/: http://www.palmbeachpost.com/news/news/crime-law/riviera-beach-police-man-smoking-flakka-wielded-ma/nmW5k/
- National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.) (2011) Guide for the care and use of laboratory animals: Eigth Edition. National Academies Press,, Washington, D.C., pp xxv, 220 pGoogle Scholar
- Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the “bath salts” constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981–1990CrossRefPubMedGoogle Scholar
- Smith MA, Witte MA (2012) The effects of exercise on cocaine self-administration, food-maintained responding, and locomotor activity in female rats: importance of the temporal relationship between physical activity and initial drug exposure. Exp Clin Psychopharmacol 20:437–446CrossRefPubMedPubMedCentralGoogle Scholar
- Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol(Philadelphia, Pa) 49:499–505Google Scholar
- Umebachi R, Aoki H, Sugita M, Taira T, Wakai S, Saito T, Inokuchi S (2016) Clinical characteristics of alpha-pyrrolidinovalerophenone (alpha-PVP) poisoning. Clinical toxicology (Philadelphia, Pa) 54: 563–567Google Scholar